tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Upstream Bio’s verekitug shows prevention of TSLP binding in respiratory disease
PremiumThe FlyUpstream Bio’s verekitug shows prevention of TSLP binding in respiratory disease
1M ago
Positive Phase 2 Results for Upstream Bio’s Verekitug Boost Stock Potential
Premium
Ratings
Positive Phase 2 Results for Upstream Bio’s Verekitug Boost Stock Potential
2M ago
Positive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug
Premium
Ratings
Positive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for Verekitug
2M ago
Positive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments
PremiumRatingsPositive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments
3M ago
Upstream Bio reports Q2 revenue $937k, consensus $317k
Premium
The Fly
Upstream Bio reports Q2 revenue $937k, consensus $317k
3M ago
Positive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment
Premium
Ratings
Positive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment
3M ago
Upstream Bio doses first patient in Phase 2 trial of verekitug in COPD
PremiumThe FlyUpstream Bio doses first patient in Phase 2 trial of verekitug in COPD
4M ago
Six new option listings and two option delistings on July 1st
Premium
The Fly
Six new option listings and two option delistings on July 1st
4M ago
Upstream Bio, Inc.: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
Premium
Ratings
Upstream Bio, Inc.: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100